Welcome to our dedicated page for Optec Internatio news (Ticker: OPTI), a resource for investors and traders seeking the latest updates and insights on Optec Internatio stock.
The OPTEC International Inc (OPTI) news page on Stock Titan aggregates company announcements, press releases, and related coverage to help readers understand how the business is evolving. OPTEC has issued updates on its OPTEC Fuel Maximizer products, PPE activities, marketplace initiatives, technology development, real estate assets, and corporate governance, giving investors and observers insight into its changing priorities and challenges.
News items have highlighted increased inquiries for the OPTEC Fuel Maximizer from private and corporate sectors, including early-stage discussions with fleet operators during periods of high fuel prices. Other releases have focused on surges in demand for PPE products such as medical and respirator masks and antigen rapid test kits, as well as the launch of online platforms for medical supply and PPE purchases. These reports show how the company has responded to shifts in fuel costs and public health conditions.
OPTEC’s communications have also covered the introduction of a new marketplace website for medical and protective products, the planned debut of patented digital temperature scanning technology integrated into cell phones and tablets, and patent filings for UVC sterilization scan technology. Corporate updates have addressed legal settlements, preferred share cancellations, leadership transitions, and a shareholder letter describing efforts to address insolvency and work with a receiver and advisors.
By reviewing this news feed, readers can follow OPTEC’s disclosures on product demand, technology development, marketplace expansion, legal developments, and turnaround efforts. The page allows users to scan historical announcements and compare how the company’s focus areas and stated strategies have shifted over time.
OPTEC International (OTC PINK:OPTI) announced a significant correction regarding its CEO's common stock ownership. Initially reported as 442,238,951 shares, the actual ownership is only 100,094 shares due to a discrepancy from the transfer agent's data. The over 442 million shares were canceled and returned to the company treasury between September and December 2020. This finding arose during due diligence for the We Shield acquisition, prompting OPTEC to pursue updated reports from the transfer agent to rectify its quarterly filings.
OPTEC International, Inc. (OTC PINK:OPTI) announced its financial results for Q3 2021, showcasing a remarkable revenue increase of 4391% to $11,576,643 compared to the same quarter last year, and a 4.49% rise over the previous quarter. Net income soared to $1,848,475, up from a loss of ($47,349) year-over-year but lower than $7,388,011 from last quarter. For the nine months, revenue reached $28,915,665, marking a 4191% increase. Total assets grew by 21% to $28,181,685, while liabilities fell 9.4%.
OPTEC International, Inc. (OTC PINK:OPTI) has appointed Rafina Innovations as the exclusive distributor in Cyprus for its product lines, enhancing its presence in the medical and pharmaceutical sectors. Rafina recently acquired C-PHARMA LTD, a well-established distributor with licenses in Euro-Asia for over-the-counter medical products. This partnership aims to expand OPTEC's market reach, particularly in the Ocean-Going Vessel Shipping industry. CEO Roger Pawson expressed optimism about this collaboration and its potential for growth.
OPTEC International, Inc. (OTC PINK:OPTI) updates shareholders about an upcoming Zoom call on April 23, 2021, hosted by CEO Roger Pawson. The company, based in Carlsbad, California, specializes in developing UV and UV-C safety products and PPE. OPTEC's Safe-Scan product line aims to address safety concerns amid the ongoing pandemic. For registration details, visit the provided Zoom link. The company emphasizes its commitment to enhancing workplace safety during these challenging times as the U.S. economy begins to reopen.
OPTEC International, Inc. (OTC PINK:OPTI), based in Carlsbad, CA, has scheduled a Zoom shareholder update call on April 23, 2021. CEO Roger Pawson will host the call, with details to be posted on the company’s website by April 13, 2021. The company focuses on developing UV and UV-C safety products and PPE, aiming to address safety concerns amid the global pandemic.
More information is available at www.optecintl.com.
OPTEC International, Inc. (OTC Pink:OPTI) announced the receipt of its first shipment of FDA-approved Antigen Home Use Rapid Test Kits at its Vista, California distribution center. Following recent FDA relaxations of emergency use regulations, these rapid tests will be available for both consumers and businesses, providing results in just 15 minutes. The company will offer two versions of the nasal swab tests, which have demonstrated a Positive Percent Agreement of 88.37% and a Negative Percent Agreement of 100%. Kits will be available online shortly, enhancing testing accessibility amid the ongoing pandemic.
OPTEC International, Inc. (OTC Pink:OPTI) announced on April 8, 2021, that it has applied for CLIA certification to enhance the reliability of its medical-related products, particularly COVID-19 testing kits. This certification aims to meet stringent industry standards, ensuring consumer trust in the company's rapid antigen and antibody tests. With the FDA's recent relaxation of EUA rules, these kits will soon be available directly to consumers, offering rapid, reliable testing options for various settings, including homes and workplaces. OPTEC plans to distribute these tests through multiple channels.
OPTEC International, Inc. (OTC PINK:OPTI) announced the impending acquisition of WeShield, an AI-driven MedTech company, aiming to enhance its position in the PPE sector. WeShield achieved over $55 million in audited revenues for 2020 and projects over $100 million in 2021. This acquisition, expected to close within 45 days, is anticipated to create synergies, increase market strength, and bolster shareholder value. OPTEC's management emphasizes the strategic importance of this deal, which will bolster OPTEC's offerings in the competitive PPE market.
OPTEC International, Inc. (OTC PINK:OPTI) announced the preparation and stockpiling of FDA EUA approved Antigen 10-minute rapid test kits for home and business use. Following a recent FDA relaxation of EUA rules, these kits will be available for purchase at affordable prices. OPTEC's tests demonstrate high reliability with a Positive Percent Agreement (PPA) of 88.37% and a Negative Percent Agreement (NPA) of 100%. The kits aim to assist in pandemic management across various sectors, including schools and healthcare.
OPTEC International, Inc. (OTC PINK:OPTI) announced it will accept Cryptocurrency payments on its E-Commerce platform and for Bulk PPE markets. The integration, planned to be fully operational by April 15, 2021, will utilize an upgraded Secure Pay gateway supporting Bitcoin, Ethereum, USDC, and DAI. CEO Roger Pawson emphasized the importance of adapting to digital currencies, noting that this move will eliminate currency conversion fees for international transactions. By 2027, the global payments industry is projected to reach $8.94 trillion.